FrancophonIA/ELRC3.0 huggingface dataset:
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Dicural 150 mg coated tablets
Latvian: DATI, KAS OBLIGĀTI JĀNORĀDA UZ BLISTERIEM JEB SLOKSNĪTĒM Dicural 150 mg tabletes suņiem
English: METHOD AND ROUTE OF ADMINISTRATION Oral use.
Latvian: LIETOŠANAS METODE UN IEVADĪŠANAS VEIDS Iekšķīgai lietošanai
English: WITHDRAWAL PERIOD Withdrawal period: Meat and offal 46 days
Latvian: Ierobežojumu periods: gaļai un subproduktiem 46 dienas
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/013 - 10 tablets EU/2/97/003/014 - 20 tablets EU/2/97/003/015 - 100 tablets
Latvian: 16. REĢISTRĀCIJAS APLIECĪBAS NUMURS EU/2/97/003/013 - 10 tabletes EU/2/97/003/014 - 20 tabletes EU/2/97/003/015 - 100 tabletes
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Dicural 15 mg coated tablets
Latvian: DATI, KAS OBLIGĀTI JĀNORĀDA UZ BLISTERIEM JEB SLOKSNĪTĒM Dicural 15 mg tabletes
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Difloxacin (as hydrochloride) 150 mg
Latvian: Dicural 150 mg difloksacīnu (difloksacīna hidrohlorīda formā) 150 mg
English: Overdosage may also give rise to oedema and swelling in the knee joints.
Latvian: Pārdozēšana var izraisīt ceļa locītavas tūsku un pietūkumu.
English: PACKAGE SIZE 1 x 250 ml 1 x 1000 ml 6 x 1000 ml
Latvian: 6 x 1000 ml
English: Treatment of Bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida, and/or Mycoplasma spp.
Latvian: Liellopiem liellopu respiratoro saslimšanu ārstēšanai (transporta drudzis, teļu pneimonija), kuras ierosina monoinfekcija vai jaukta infekcija ar Pasteurella haemolytica, Pasteurella multocida un/vai Mycoplasma spp.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 100 mg/ml oral solution for chickens and turkeys
Latvian: VETERINĀRO ZĀĻU NOSAUKUMS Dicural 100 mg/ml šķīdums iekšķīgai lietošanai vistām un tītariem.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/007 - 10 tablets EU/2/97/003/008 - 20 tablets EU/2/97/003/009 - 100 tablets
Latvian: 16. REĢISTRĀCIJAS APLIECĪBAS NUMURS (-I) EU/2/97/003/007 - 10 tabletes EU/2/97/003/008 - 20 tabletes EU/2/97/003/009 - 100 tabletes
English: Shelf life after first use of the product: 28 days
Latvian: Uzglabāšanas laiks pēc pirmās tiešā iepakojuma atvēršanas: 28 dienas.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/010 - 10 tablets EU/2/97/003/011 - 20 tablets EU/2/97/003/012 - 100 tablets
Latvian: 16. REĢISTRĀCIJAS APLIECĪBAS NUMURS (-I) EU/2/97/003/010 - 10 tabletes EU/2/97/003/011 - 20 tabletes EU/2/97/003/012 - 100 tabletes
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/004 - 10 tablets EU/2/97/003/005 - 20 tablets EU/2/97/003/006 - 100 tablets
Latvian: 16. REĢISTRĀCIJAS APLIECĪBAS NUMURS (-I) EU/2/97/003/004 - 10 tabletes EU/2/97/003/005 - 20 tabletes EU/2/97/003/006 - 100 tabletes
English: To be supplied only on veterinary prescription..
Latvian: Recepšu veterinārās zāles.
English: Lactose
Latvian: PAŅĒMIENA
English: Muscle Fat Liver Kidney
Latvian: Muskulis Tauki Akna Niere
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Dicural 50 mg/ml, solution for injection for cattle and dogs CARTON for 50 ml vial
Latvian: INFORMĀCIJA, KURAI JĀBŪT UZ ĀRĒJĀ IEPAKOJUMA Dicural 50mg/ml šķīdums injekcijām liellopiem un suņiem
English: Cattle: Treatment of Bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida, and/or Mycoplasma spp.
Latvian: Liellopiem: - liellopu respiratoro saslimšanu ārstēšanai (transporta drudzis, teļu pneimonija), kuras ierosina monoinfekcija vai jaukta infekcija ar Pasteurella haemolytica, Pasteurella multocida un/vai Mycoplasma spp.
English: Tel: + 0040 21 207 28 93
Latvian: Pfizer Romania SRL Tel: + 0040 21 207 28 93
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Dicural 50 mg coated tablets
Latvian: DATI, KAS OBLIGĀTI JĀNORĀDA UZ BLISTERIEM JEB SLOKSNĪTĒM Dicural 50 mg tabletes suņiem
English: Annex II of Council Regulation (EEC) No 2377/90 Oral solution:
Latvian: 2377/90 II pielikumā saskaņā ar šeit norādīto tabulu.
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Difloxacin (as hydrochloride) 50 mg
Latvian: Dicural 50 mg difloksacīnu (difloksacīna hidrohlorīda formā) 50 mg
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Difloxacin (as hydrochloride) 15 mg
Latvian: Difloksacīnu (difloksacīna hidrohlorīda formā) 15mg
English: Small
Latvian: Niere
English: Coated tablets
Latvian: 100 tabletes
English: PACKAGE LEAFLET FOR Dicural 100 mg/ml oral solution for chickens and turkeys
Latvian: LIETOŠANAS INSTRUKCIJA Dicural 100 mg/ml šķīdums iekšķīgai lietošanai vistām un tītariem.
English: Do not store above 25-C.
Latvian: Uzglabāt temperatūrā līdz 25o C.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 50 mg coated tablets for dogs
Latvian: Dicural 50 mg tabletes suņiem
English: Benzyl alcohol Propylene glycol Arginine
Latvian: Nātrija kroskarmeloze Mikronizēts alus raugs Aromātiska aknu smaržviela
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Dicural 50 mg/ml, solution for injection for cattle and dogs 50 ml vial label
Latvian: DATI, KAS OBLIGĀTI JĀNORĀDA UZ MAZA IZMĒRA TIEŠĀ IEPAKOJUMA Dicural 50mg/ml šķīdums injekcijām liellopiem un suņiem
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 15 mg coated tablets for dogs
Latvian: Dicural 15 mg tabletes suņiem
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 150 mg coated tablets for dogs
Latvian: Dicural 150 mg tabletes suņiem.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 50 mg/ml solution for injection for cattle and dogs.
Latvian: 50 mg/ml šķīdums injekcijām liellopiem un suņiem.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 100 mg coated tablets for dogs
Latvian: Dicural 100 mg tabletes suņiem.
English: The recommended dose is a single injection of 5.0 mg difloxacin/kg bodyweight Treatment must be continued with Dicural coated tablets (see that SPC)
Latvian: Ārstēšanu jāturpina ar Dicural apvalkotām tabletēm (skat.
English: Annex I of Council Regulation (EEC) No 2377/90 Pharmacologically active substance residue
Latvian: 2377/90 I pielikumā saskaņā ar šeit norādīto tabulu.
English: Skilarence is available as tablets (30 and 120 mg).
Latvian: Skilarence ir pieejamas tabletēs (30 un 120 mg).
English: The full EPAR for Skilarence can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Latvian: Pilns Skilarence EPAR teksts ir atrodams aģentūras tīmekļa vietnē: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Tablets should be swallowed whole during or immediately after a meal.
Latvian: Tabletes jānorij veselas maltītes laikā vai tūlīt pēc tās.
English: This is a summary of the European public assessment report (EPAR) for Skilarence.
Latvian: Šis ir Eiropas Publiskā novērtējuma ziņojuma (EPAR) kopsavilkums par Skilarence.
English: What measures are being taken to ensure the safe and effective use of Skilarence?
Latvian: Kas tiek darīts, lai garantētu drošu un efektīvu Skilarence lietošanu?
English: It is not intended to provide practical advice on how to use Skilarence.
Latvian: Tas nav paredzēts kā praktiski ieteikumi par Skilarence lietošanu.
English: Other information about Skilarence
Latvian: Cita informācija par Skilarence
English: The main measure of effectiveness was the proportion of patients who achieved a 75% reduction in their score for disease severity.
Latvian: Galvenais iedarbīguma rādītājs bija to pacientu daļa, kas sasniedza 75% slimības smaguma rezultāta samazinājumu.
English: Why is Skilarence approved?
Latvian: Kāpēc Skilarence tika apstiprinātas?
English: The CHMP considered that the main study has shown Skilarence's short-term effectiveness, and published studies with similar medicines show that the effectiveness is maintained with continued use.
Latvian: CHMP uzskatīja, ka pamatpētījumā ir pierādīta Skilarence īstermiņa iedarbība, un publicētajos pētījumos, kas veikti ar līdzīgām zālēm, tika uzrādīts, ka, nepārtraukti lietojot, iedarbīgums saglabājas.
English: The company that markets Skilarence will supply educational materials to healthcare professionals about the risk of serious infections, including PML, and how to minimise this risk.
Latvian: Uzņēmums, kas piedāvā tirgū Skilarence, izsniegs izglītojošus materiālus veselības aprūpes speciālistiem par nopietnu infekciju risku, tostarp PML, un to, kā mazināt šādu risku.
English: Skilarence dimethyl fumarate
Latvian: Skilarence dimetilfumarāts
English: After 16 weeks of treatment, 37% of patients taking Skilarence achieved this reduction, compared with 15% taking placebo and 40% taking Fumaderm .
Latvian: Pēc 16 nedēļu terapijas 37% pacientu, kuri lietoja Skilarence, sasniedza šī rezultāta samazinājumu salīdzinājumā ar 15% pacientu, kuri lietoja placebo, un 40% pacientu, kuri lietoja Fumaderm.
English: The starting dose is 30 mg once a day and the dose is increased every week according to the schedule shown in the package leaflet until the psoriasis starts improving or until the patient is taking the maximum dose of 240 mg three times a day.
Latvian: Sākumdeva ir 30 mg reizi dienā, un devu palielina reizi nedēļā atbilstoši grafikam, kas norādīts zāļu lietošanas instrukcijā, līdz psoriāzes simptomi mazinās vai līdz pacients ir sasniedzis maksimālo devu 240 mg trīs reizes dienā.
English: Most side effects are mild or moderate.
Latvian: Vairums blakusparādību ir vieglas vai vidēji smagas.
English: What is Skilarence and what is it used for?
Latvian: Kas ir Skilarence un kāpēc tās lieto?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Skilarence's benefits are greater than its risks and recommended that it be approved for use in the EU.
Latvian: Aģentūras Cilvēkiem paredzēto zāļu komiteja (CHMP) nolēma, ka ieguvums, lietojot Skilarence, pārsniedz šo zāļu radīto risku, un ieteica apstiprināt šīs zāles lietošanai ES.
English: Skilarence can only be obtained with a prescription and it should be used under the supervision of a doctor who has experience in diagnosing and treating psoriasis.
Latvian: Skilarence var iegādāties tikai pret recepti, un tās jālieto tāda ārsta uzraudzībā, kam ir pieredze psoriāzes diagnostikā un ārstēšanā.
English: It must also not be used by women during pregnancy or if breast-feeding.
Latvian: Tās nedrīkst lietot arī grūtnieces un sievietes, kas baro ar krūti.
English: Because Skilarence reduces the activity of the immune system, there is a risk of serious infections, including progressive multifocal leukoencephalopathy (PML, a brain infection), but the risk can be minimised by regular tests for white blood cell counts and stopping treatment if necessary.
Latvian: Tā kā Skilarence samazina imūnsistēmas aktivitāti, pastāv nopietnu infekciju risks, tostarp multifokālās leikoencefalopātijas (PML, smadzeņu infekcijas) risks, bet to var mazināt ar regulārām asinsanalīzēm, kurās nosaka balto asins šūnu skaitu, vai pārtraucot terapiju, ja nepieciešams.
English: Skilarence contains the active substance dimethyl fumarate.
Latvian: Skilarence satur aktīvo vielu dimetilfumarātu.
English: Psoriasis results from over-activity of the body's immune (defence) system.
Latvian: Psoriāze rodas no organisma imūnsistēmas pārmērīgas aktivitātes.
English: A main study involving 704 patients with moderate to severe plaque psoriasis found that Skilarence was more effective than placebo (dummy treatment) at treating the disease and as effective as Fumaderm (a psoriasis medicine that contains dimethyl fumarate and monoethyl fumarate).
Latvian: Pamatpētījumā, kurā piedalījās 704 pacienti ar vidēji smagu vai smagu perēkļaino psoriāzi, tika konstatēts, ka zāles Skilarence ir iedarbīgākas par placebo (fiktīu ārstēšanu) un tikpat iedarbīgas kā Fumaderm (zāles pret psoriāzi, kas satur dimetilfumarātu un monoetilfumarātu).
English: What benefits of Skilarence have been shown in studies?
Latvian: Kādas bija Skilarence priekšrocības šajos pētījumos?
English: The most common side effects with Skilarence (which may affect more than 1 in 10 people) are effects on the digestive system (diarrhoea, bloating, belly ache and nausea), flushing (reddening of the skin) and low levels of lymphocytes (type of white blood cells) or of white blood cells in general.
Latvian: Visbiežākās Skilarence blakusparādības (kas var rasties vairāk nekā 1 no 10 cilvēkiem) ir iedarbība uz gremošanas sistēmu (caureja, vēdera uzpūšanās, sāpes vēderā un slikta dūša), pietvīkums (ādas apsārtums) un zems limfocītu (balto asins šūnu paveida) līmenis vai balto asins šūnu samazināts daudzums kopumā.
English: It is thought to act on T cells (a type of white blood cell that forms part of the immune system) to prevent the cells from producing substances that cause inflammation and lead to psoriasis.
Latvian: Tiek uzskatīts, ka aktīvā viela iedarbojas uz T šūnām (balto asins šūnu paveidu, kas ir daļa no imūnsistēmas), lai novērstu iespēju šūnām radīt vielas, kas izraisa iekaisumu un pēc tam psoriāzi.
English: Skilarence must not be used in patients who have severe problems of the digestive system, liver or kidneys.
Latvian: Skilarence nedrīkst lietot pacienti ar smagiem gremošanas sistēmas, aknu vai nieru darbības traucējumiem.
English: The doctor may reduce the dose when the psoriasis has been brought under control.
Latvian: Ārsts var samazināt devu, kad ir izdevies stabilizēt psoriāzes stāvokli.
English: For practical information about using Skilarence, patients should read the package leaflet or contact their doctor or pharmacist.
Latvian: Lai saņemtu praktisku informāciju par Skilarence lietošanu, pacientiem jāizlasa zāļu lietošanas instrukcija vai jāsazinās ar ārstu vai farmaceitu.
English: For more information about treatment with Skilarence, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Latvian: Lai saņemtu sīkāku informāciju par ārstēšanu ar Skilarence, izlasiet zāļu lietošanas instrukciju (kas arī ir EPAR daļa) vai sazinieties ar ārstu vai farmaceitu.
English: How does Skilarence work?
Latvian: Kā Skilarence darbojas?
English: The active substance in Skilarence, dimethyl fumarate, reduces the activity of the immune system.
Latvian: Skilarence aktīvā viela dimetilfumarāts samazina imūnsistēmas aktivitāti.
English: It is used in patients with moderate or severe disease for whom treatments applied direct to the skin do not work well enough.
Latvian: Zāles lieto pacientiem ar vidēji smagu līdz smagu slimību, kuriem tieša zāļu uzklāšana uz ādas nav pietiekami iedarbīga.
English: Skilarence is a medicine used to treat plaque psoriasis, a disease that causes thickened, red and inflamed areas of skin with scaly patches.
Latvian: Psoriāze ir slimība, kas izraisa sabiezinātus, sarkanus un iekaisušus laukumus uz ādas, kas ir pārklāti ar zvīņainiem plankumiem.
English: For the full list of all side effects reported with Skilarence, see the package leaflet.
Latvian: Pilnu visu ziņoto blakusparādību sarakstu, lietojot Skilarence, skatīt zāļu lietošanas instrukcijā.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Skilarence have also been included in the summary of product characteristics and the package leaflet.
Latvian: Turklāt zāļu aprakstā un lietošanas instrukcijā tika ietverti ieteikumi un piesardzības pasākumi, kas jāievēro veselības aprūpes speciālistiem un pacientiem, lai garantētu drošu un efektīvu Skilarence lietošanu.
English: What are the risks associated with Skilarence?
Latvian: Kāds risks pastāv, lietojot Skilarence?
English: How is Skilarence used?
Latvian: Kā lieto Skilarence?
English: This summary was last updated in 06-2017.
Latvian: Skilarence EMA/377397/2017
English: PARANOVA Rajatorpantie 41 C 01640 Vantaa Finland
Latvian: Paranova Oy Rajatorpantie 41 C 01640 Vantaa Finland
English: Aktiengesellschaft Industriestr.
Latvian: Hexal Aktiengesellschaft Industriestr.
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for Combined hormonal contraceptives
Latvian: ZĀĻU NOSAUKUMI, ZĀĻU FORMAS, STIPRUMS, LIETOŠANAS VEIDS UN REĢISTRĀCIJAS APLIECĪBU ĪPAŠNIEKI DALĪBVALSTĪS
English: Frederic Mompou, 5 08960 Sant Just Desvern
Latvian: Frederic Mompou, 5 08960 Sant Just Desvern Barcelona
English: Belgium MYLAN BVBA/SPRL Terhulpsesteenweg 6A 1560 Hoeilaart
Latvian: MYLAN BVBA/SPRL Terhulpsesteenweg 6A 1560 Hoeilaart Belgium
English: Via Lincoln 7/A, 20092 Cinisello Balsamo (MI) Italy
Latvian: Via Lincoln 7/A, 20092 Cinisello Balsamo (MI)
English: Str. Livezeni nr. 7A, 540472 Târgu Mureş, România.
Latvian: 7A, 540472 Târgu Mureş, România.
English: Slovak Republic Stada Arzneimittel AG, Stadastrasse 2-8,
Latvian: Nīderlande Stada Arzneimittel AG, Stadastrasse 2-8,
English: Organon (Ireland) Ltd, PO Box 2857, Drynam Road, Swords,
Latvian: Ltd, PO Box 2857, Drynam Road, Swords,
English: Belgium EFFIK BENELUX Lenniksebaan 451
Latvian: Luksemburga EFFIK BENELUX Lenniksebaan 451
English: 06796 Brehna
Latvian: 06796 Brehna Germany
English: 9 Riverwalk National Digital Park Citywest Business Campus
Latvian: National Digital Park Citywest Business Campus Dublin 24
English: IDD (International Drug Development) 5, rue Simonet 75013 PARIS FRANCE
Latvian: IDD (International Drug Development) 5, rue Simonet 75013 Paris
English: Farmaceuticos, Lda Edifício Cyprium, Av. 25 de Abril, 15, 2º F 2795-195 Linda-aVelha
Latvian: Teva Pharma - Produtos Farmaceuticos, Lda Edifício Cyprium, Av. 25 de Abril, 15, 2º F 2795-195 Linda-a-Velha Portugal
English: Teva Danmark A/S, Parallelvej 10-12, DK-2800 Kongens Lyngby,
Latvian: Teva Danmark A/S, Parallelvej 10-12, DK-2800 Kongens Lyngby, Denmark
English: Alameda da Beloura Edificio 1, 2º Escritorio 15
Latvian: Alameda da Beloura Edificio 1, 2º
English: 1070 Anderlecht
Latvian: 1070 Anderlecht Belgium
English: 1800 Vilvoorde
Latvian: 1800 Vilvoorde Belgium
English: Janssen-Cilag Limited 50-100 Holmers Farm Way
Latvian: Lielbritānija Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe
English: Pelplińska 19 83-200 Starogard Gdański
Latvian: 83-200 Starogard Gdański Poland
English: Teva Pharmaceuticals Polska Sp. z o.o.
Latvian: Teva Pharmaceuticals Polska Sp. z o.o. ul.
English: Nagano III, U
Latvian: Nagano III,
English: Merck Sharp and Dohme de España, S.A Josefa Valcárcel, 38 28027 Madrid Spain
Latvian: Merck Sharp and Dohme de España, S.A c/ Josefa Valcárcel, 38 28027 Madrid España (Spain)
English: Radlická 3185/1c
Latvian: Radlická 3185/1c 150 00 Praha 5
English: Otto-Schott-Straße 15 07745 Jena Deutschland
Latvian: KG Otto-Schott-Straße 15 07745 Jena
English: Luxembourg Teva Pharma Belgium N.V.
Latvian: Luksemburga Teva Pharma Belgium N.V.
English: BIAL INDUSTRIAL FARMACEUTICA, S.A. Parque Científico y Tecnológico de Bizkaia,
Latvian: Parque Científico y Tecnológico de Bizkaia,
English: MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
Latvian: MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung
English: BAYER HELLAS AG Sorou 18-20
Latvian: BAYER HELLAS AG Sorou street 18-20 Maroussi
English: Lagedijk 1-3;
Latvian: Nīderlande WeCare, Lagedijk 1-3;
English: WYETH MEDICA IRELAND Newbridge Ireland
Latvian: WYETH MEDICA IRELAND Little Connell Newbridge
English: Teva Pharmaceuticals Bulgaria EOOD Gogol 15
Latvian: Teva Pharmaceuticals Bulgaria EOOD
English: Slovak Republic Actavis Group PTC ehf Reykjavikurvegi 76-78
Latvian: Nīderlande Actavis Group PTC ehf Reykjavikurvegi 76-78
English: Janssen - Cilag Pharma GmbH Vorgartenstraße 206b A-1020 Wien Austria
Latvian: Janssen - Cilag Pharma GmbH Vorgartenstraße 206b A-1020 Wien
English: Vaginal use
Latvian: Vaginālai lietošanai
English: 48170 Zamudio Vizcaya
Latvian: 48170 Zamudio (Vizcaya) Spain
English: "ARAC" At Regulatory Affairs Consulting GmbH
Latvian: "ARAC" At Regulatory Affairs Consulting GmbH Kichengasse 48/3
English: Belgium Teva Pharma Belgium N.V.
Latvian: Teva Pharma Belgium N.V.
English: Bayer Sante 220 avenue de la Recherche 59120 Loos France
Latvian: 220 avenue de la Recherche 59120 Loos
English: Luxembourg Ratiopharm GmbH Graf-Arco-Strasse 3
Latvian: Luksemburga Ratiopharm GmbH Graf-Arco-Strasse 3
English: Famy Care Europe Ltd. One Wood Street EC2V 7WS
Latvian: Famy Care Europe Ltd One Wood Street EC2V 7WS London United Kingdom
English: A. Menarini Industrie Farmaceutiche Riunite s.r.l., via Sette Santi, 3
Latvian: A. Menarini Industrie Farmaceutiche Riunite s.r.l., via Sette Santi, 3 - 50131 Florence
English: 12277 Berlin Germany
Latvian: 12277 Berlin
English: Luxembourg Madaus GmbH Colonia Allee 15
Latvian: Luksemburga Madaus GmbH Colonia Allee 15
English: 154 51 N. Psychiko, Greece
Latvian: 243 Messoghion Avenue, 154 51 N. Psychiko, Greece
English: Jenapharm GmbH & Co. KG
Latvian: Jenapharm GmbH & Co.
English: 42110 Ólvega (Soria) Spain
Latvian: De Ágreda 31 42110 Ólvega (Soria)
English: WYETH FARMA, S.A. Ctra.
Latvian: WYETH FARMA, S.A.
English: 5026 RH TILBURG The Netherlands
Latvian: 5026 RH Tilburg
English: Rivium Westlaan 142 2909 LD Capelle a/d IJssel
Latvian: 2909 LD Capelle a/d IJssel The Netherlands
English: Teva The Netherlands B.V.
Latvian: Nīderlande Teva Nederland B.V.
English: Cimizt Tablets 150 mg/30 mg
Latvian: Cimizt Tabletes 150 mg/30 mg
English: 1541 KA Koog aan de Zaan,
Latvian: 1541 KA Koog aan de Zaan, The Netherlands
English: Czech Republic Pfizer, spol.
Latvian: Pfizer, spol.
English: Slovak Republic VIVAX EuroAsia s.r.o.
Latvian: VIVAX EuroAsia s.r.o.
English: 92787 ISSY LES MOULINEAUX cedex 9 FRANCE
Latvian: 92787 Issy-les-Moulineaux cedex 9
English: 1000 Ľubľana Slovenia
Latvian: 1000 Ľubľana
English: Romania
Latvian: România
English: Janssen-Cilag GmbH Johnson & Johnson Platz 1
Latvian: Janssen-Cilag GmbH Johnson & Johnson Platz 1 41470 Neuss
English: 85540 Haar Germany
Latvian: 85540 Haar
English: Gyömrői út 19-21 HU-1103 Budapest Hungary
Latvian: Gyömrői ut 19-21, H-1103 Budapest, Hungary
English: Belgium L.F. WILL & CIE SA Rue du Manil 80
Latvian: L.F. WILL & CIE SA Rue du Manil 80 1301 Wavre Belgium
English: UAB „Johnson & Johnson“
Latvian: UAB „Johnson & Johnson“ Geležinio Vilko g.
English: HU-1103 Budapest
Latvian: HU-1103 Budapest Hungary
English: Geležinio Vilko g. 18A LT-08104 Vilnius Lithuania
Latvian: 18A LT-08104 Vilnius Lithuania
English: LadeePharma LTD. Lajos street 48-66 E Budapest 1036
Latvian: LadeePharma Kft Lajos utca 48-66 H-1036 Budapest Hungary
English: 48940 Lamiaco-Lejona (Vizcaya)
Latvian: Maximo Aguirre, 14. 48940 Lamiaco-Lejona (Vizcaya)
English: Temapharm Sp. z o.o.
Latvian: Temapharm Sp. z o.o. ul.
English: 49 avenue Georges Pompidou 92593 LEVALLOISPERRET Cedex FRANCE
Latvian: 49 avenue Georges Pompidou 92593 Levallois-Perret Cedex France
English: SymPhar Sp. z o.o.
Latvian: SymPhar Sp. z o.o. ul.
English: Germany betapharm Arzneimittel GmbH Kobelweg 95
Latvian: Vācija betapharm Arzneimittel GmbH Kobelweg 95
English: Navatejera,
Latvian: Ind., Navatejera
English: Pfizer Healthcare Ireland
Latvian: Pfizer Healthcare Ireland 9 Riverwalk
English: Millinette ED Micrograms Film-Coated Tablets 15 /
Latvian: Millinette ED Micrograms FilmCoated Tablets 15 /
English: N.V. Organon Kloosterstraat 6 5349 AB, Oss The Netherlands
Latvian: Organon Kloosterstraat 6 5349 AB, Oss The Netherlands
English: CT 13 9NJ
Latvian: Kent CT13 9NJ United Kingdom
English: Janssen-Cilag A/S, Postbox 149, Hammerbakken 19, DK-3460 Birkerød, Denmark
Latvian: Janssen-Cilag A/S, Hammerbakken 19 DK-3460 Birkerød Denmark
English: Slovak Republic LADEEPHARMA Slovakia s.r.o.
Latvian: LADEEPHARMA Slovakia s.r.o.
English: The Netherlands betapharm Arzneimittel GmbH Kobelweg 95
Latvian: Nīderlande betapharm Arzneimittel GmbH Kobelweg 95
English: Rowex Ltd Bantry Co. Cork Ireland
Latvian: Rowex Ltd Bantry Co.
English: Morningside Healthcare Limited, 115 Narborough Road, Leicester LE3 0PA United Kingdom
Latvian: 115 Narborough Road, Leicester LE3 0PA
English: RANBAXY PHARMACIE GENERIQUES 11-15 Quai Dion Bouton
Latvian: RANBAXY PHARMACIE GENERIQUES 11-15 Quai Dion Bouton 92816 Puteaux Cedex France
English: Slovak Republic Bayer, spol.
Latvian: Bayer, spol.